Compared with the BG group, mRNA expression of Nfatc4 was elevated in both the BSC group (p < 0.001) and the CMLc group (p < 0.01) (but not the CML group) (Fig. 4c). Here, NFATC4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.